Scrip ID
VANTABIO
Vanta Bioscience Limited has intimated BSE Limited about an upcoming board meeting scheduled for Friday, November 13, 2026 at 06:00 PM. The meeting will be held at the registered office of the Company.
The primary agenda of the board meeting includes consideration and approval of:
- Standalone unaudited Financial Results for the half year ended September 30, 2026
- Consolidated unaudited Financial Results for the half year ended September 30, 2026
The board will also take note of the Limited Review Report issued by the Statutory Auditors on these financial results.
In continuation of the previous intimation dated September 29, 2026, the Trading Window for all designated persons as defined under the Company's Insider Trading Policy remains closed from October 01, 2026 till November 15, 2026 (both days inclusive).